Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Ligand Pharmaceuticals Incorporated, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Ligand Pharmaceuticals Incorporated June 5, 202694.4%
-
Ligand Pharmaceuticals Incorporated June 9, 202593.9%
-
Ligand Pharmaceuticals Incorporated June 14, 202495.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Ligand Pharmaceuticals Incorporated | Option exercise | +2,145 | $66.13 | $141,849 |
| Jun 16, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −2,145 | $254.00 | $544,830 |
| Jun 5, 2026 | Ligand Pharmaceuticals Incorporated | Grant or award | +836 | — | — |
| Mar 23, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −1,000 | $207.87 | $207,870 |
| Mar 3, 2026 | Ligand Pharmaceuticals Incorporated | Option exercise | +2,034 | $69.51 | $141,383 |
| Mar 3, 2026 | Ligand Pharmaceuticals Incorporated | Open-market sale | −2,034 | $201.50 | $409,851 |
| Jun 6, 2025 | Ligand Pharmaceuticals Incorporated | Grant or award | +1,209 | — | — |
| Apr 1, 2025 | Ligand Pharmaceuticals Incorporated | Option exercise | +2,406 | $52.30 | $125,834 |
| Jun 14, 2024 | Ligand Pharmaceuticals Incorporated | Grant or award | +1,252 | — | — |
| Mar 5, 2024 | Ligand Pharmaceuticals Incorporated | Option exercise | +2,893 | — | — |
| Mar 5, 2024 | Ligand Pharmaceuticals Incorporated | Open-market sale | −1,893 | $74.30 | $140,650 |
| Jun 9, 2023 | Ligand Pharmaceuticals Incorporated | Grant or award | +1,142 | — | — |
| May 10, 2023 | Ligand Pharmaceuticals Incorporated | Option exercise | +6,408 | — | — |
| May 10, 2023 | Ligand Pharmaceuticals Incorporated | Open-market sale | −6,408 | $77.13 | $494,249 |
Questions about Stephen L. Sabba
What boards is Stephen L. Sabba on?
Stephen L. Sabba sits on the board of Ligand Pharmaceuticals Incorporated.
How long has Stephen L. Sabba served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.